PHARMAC responds to Richard Milne on discounting health benefits and costs.
Metcalfe
Scott
S
Brougham
Matthew
M
Moodie
Peter
P
Grocott
Rachel
R
D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000639:trends*; D009520:New Zealand